跳到正文

Suvretta Capital Management, LLC 13F 持仓 · 2026年Q2

Suvretta Capital Management 在 2026年Q2(报告期截至 2026-06-30)的 SEC 13F 申报中报告了 95 只证券,申报市值合计 54.68 亿美元。前几大持仓:SPY(12.97%)、MANE(9.37%)、ARQT(5.96%)。本季前 25 大持仓中:新建仓 2 只、增持 11 只、减持 4 只。

排名代码公司市值占组合股数变动
1SPYSTATE STR SPDR S&P 500 ETF T$709.4M12.97%950,000增持
2MANEVERADERMICS INC$512.5M9.37%4.2M持平
3ARQTARCUTIS BIOTHERAPEUTICS INC$326.1M5.96%12.4M增持
4LEGNLEGEND BIOTECH CORP$204.2M3.73%7.1M减持
5PVLAPALVELLA THERAPEUTICS INC NE$173.5M3.17%1.1M减持
6AVBPARRIVENT BIOPHARMA INC$156.9M2.87%4.5M增持
7BNTCBENITEC BIOPHARMA INC$154.5M2.83%11.5M持平
8BHVNBIOHAVEN LTD$153.1M2.80%10.3M持平
9AMDADVANCED MICRO DEVICES INC$149.4M2.73%257,240持平
10RCUSARCUS BIOSCIENCES INC$147.3M2.69%4.8M减持
11TSMTAIWAN SEMICONDUCTOR MANUFAC$145.5M2.66%304,627增持
12NVDANVIDIA CORPORATION$144.2M2.64%720,609增持
13EYPTEYEPOINT INC$118.6M2.17%8.3M持平
14SYYSYSCO CORP$118.0M2.16%1.4M增持
15GEGE AEROSPACE$116.0M2.12%310,262持平
16IMTXIMMATICS N.V$113.4M2.07%11.2M持平
17MGMMGM RESORTS INTERNATIONAL$111.2M2.03%2.3M增持
18METAMETA PLATFORMS INC$99.0M1.81%175,807增持
19CAPRCAPRICOR THERAPEUTICS INC$98.6M1.80%4.1M增持
20KURAKURA ONCOLOGY INC$94.1M1.72%8.6M持平
21GLUEMONTE ROSA THERAPEUTICS INC$85.9M1.57%3.5M减持
22AVLNAVALYN PHARMACEUTICALS INC$82.4M1.51%2.5M新建仓
23HDHOME DEPOT INC$79.7M1.46%226,053增持
24HUTHUT 8 CORP$77.3M1.41%670,000新建仓
25COFCAPITAL ONE FINL CORP$66.8M1.22%333,098增持

来源:SEC 13F 申报文件 · 截至 2026-06-30

本期 13F-HR 中的全部持仓,以及相对上季度的变化。

13F 持仓,最新季度

来源SEC EDGAR13F-HR